Ruofei Li, a Class of 2025 master’s student specializing in cardiovascular medicine, is supervised by associate researcher Jing Li, is currently studying at the Institute of cardiovascular disease, the Second Affiliated Hospital of Dalian Medical University. Her current research direction is mainly to study the mechanism of deubiquitinase regulating doxorubicin-induced cardiotoxicity.
Shuai Wang Tri Lab